Hugel, Inc. (145020.KQ) — Stock Score Summary

Hugel, Inc. (145020.KQ) has a MoatMap StockRank of 70/100 based on Quality (78/100), Value (34/100), and Momentum (40/100) factor scores. The current signal is BUY. Hugel is a high-margin medical aesthetics player with strong domestic market share, but it lacks alignment with the core macro inflection themes and faces intense global competition in the botulinum toxin space.

Hugel, Inc. is a leading South Korean medical aesthetics company that manufactures and distributes botulinum toxin, dermal fillers, and cosmetic products. The company's competitive moat is sustained by its dominant market share in South Korea and its expanding regulatory approvals in major global markets, including China, Europe, and the US. Hugel operates as a highly profitable, market-leading player in the global medical aesthetics industry.

Key Financial Metrics

Price$151.91
Market Cap$1.8B
P/E (Forward)14.23
Return on Equity16.4%
Return on Invested Capital20.1%
Debt/Equity2.76
Gross Margin78.5%
Operating Margin40.8%
Revenue Growth29.9%
Free Cash Flow$42K

Hugel, Inc. operates in the Biotechnology industry, part of the Healthcare sector (South Korea).

Frequently Asked Questions

What is Hugel, Inc.’s (145020.KQ) StockRank?
MoatMap’s StockRank for Hugel, Inc. (145020.KQ) is 70/100, with a Buy signal. It is a composite of Quality (78), Value (34), and Momentum (40) factor ranks across MoatMap’s 19,000+ stock universe.
Does Hugel, Inc. have an economic moat?
Hugel, Inc. (145020.KQ) has a Quality factor score of 78/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Hugel, Inc. a buy, hold, or sell?
MoatMap’s current signal for Hugel, Inc. (145020.KQ) is Buy, based on a StockRank of 70/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Hugel, Inc. in?
Hugel, Inc. (145020.KQ) operates in the Healthcare sector, specifically the Biotechnology industry (South Korea).
Browse all ranked stocks145020.KQ deep dive reportAI ChampionsHow we score stocksSense-check another stock